| RS2147806122 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Hematuria, X-linked Alport syndrome |
| RS2147806786 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa2, Glycogen storage disease IXa2 |
| RS2147806873 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147807115 |
PHKA2
|
Health Risk |
Pathogenic |
Aland island eye disease, Aland island eye disease |
| RS2147809070 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147809078 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147809122 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147810144 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147810410 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147810566 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147811858 |
MED12
|
Health Risk |
Pathogenic |
FG syndrome 1, FG syndrome |
| RS2147812145 |
AKT3
|
Health Risk |
Pathogenic |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 |
| RS2147812232 |
RNF113A
|
Health Risk |
Likely pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS2147812233 |
RNF113A
|
Health Risk |
Conflicting classifications of pathogenicity |
Trichothiodystrophy 5, nonphotosensitive |
| RS2147813326 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147813799 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147813821 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147813867 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147814409 |
WDR45
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147814431 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147814810 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147814841 |
WDR45
|
Health Risk |
Pathogenic |
— |
| RS2147814859 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147814875 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147814944 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147815120 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147815135 |
WDR45
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147815172 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147815209 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147815304 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147815446 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147815668 |
WDR45
|
Health Risk |
Pathogenic |
— |
| RS2147816209 |
WDR45
|
Health Risk |
Pathogenic |
— |
| RS2147816288 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147816332 |
WDR45
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147816494 |
WDR45
|
Health Risk |
Pathogenic |
— |
| RS2147816498 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147816654 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147816920 |
MED12
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2147817375 |
WDR45
|
Health Risk |
Pathogenic |
— |
| RS2147817379 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147817417 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147817625 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147817628 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147817629 |
WDR45
|
Health Risk |
Pathogenic |
— |
| RS2147817681 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147817901 |
WDR45
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS2147818976 |
CHM
|
Health Risk |
Pathogenic/Likely pathogenic |
Choroideremia, Choroideremia |
| RS2147819159 |
CHM
|
Health Risk |
Likely pathogenic |
— |
| RS2147819355 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147819369 |
-
|
Health Risk |
Likely pathogenic |
Choroideremia, Choroideremia |
| RS2147819501 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147819583 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147820825 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147820987 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147820991 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147822607 |
MED12
|
Health Risk |
Likely pathogenic |
FG syndrome 1, FG syndrome 1 |
| RS2147823333 |
MED12
|
Health Risk |
Pathogenic |
FG syndrome 1, Cholestasis-pigmentary retinopathy-cleft palate syndrome |
| RS2147825407 |
HADHB
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147825515 |
HADHB
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147826070 |
MED12
|
Health Risk |
Pathogenic |
FG syndrome 1, Cholestasis-pigmentary retinopathy-cleft palate syndrome |
| RS2147826312 |
MED12
|
Health Risk |
Likely pathogenic |
— |
| RS2147827179 |
MED12
|
Health Risk |
Likely pathogenic |
FG syndrome, FG syndrome |
| RS2147829163 |
DNAAF6
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2147829167 |
MED12
|
Health Risk |
Pathogenic |
FG syndrome 1, Cholestasis-pigmentary retinopathy-cleft palate syndrome |
| RS2147829909 |
HADHB
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147830061 |
HADHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147831991 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147832276 |
HADHB
|
Health Risk |
Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147832375 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147832420 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147832572 |
DOCK6
|
Health Risk |
Likely pathogenic |
— |
| RS2147832635 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147833223 |
CASK
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS2147833779 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS2147833856 |
SLC16A2
|
Health Risk |
Likely pathogenic |
— |
| RS2147833877 |
SLC16A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Allan-Herndon-Dudley syndrome |
| RS2147833883 |
SLC16A2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2147834066 |
SLC16A2
|
Health Risk |
Likely pathogenic |
— |
| RS2147839335 |
MED12
|
Health Risk |
Pathogenic |
FG syndrome 1, Cholestasis-pigmentary retinopathy-cleft palate syndrome |
| RS2147839517 |
TANGO2
|
Health Risk |
Pathogenic |
— |
| RS2147840474 |
SERPINA7
|
Health Risk |
association |
Thyroxine-binding globulin quantitative trait locus, Thyroxine-binding globulin quantitative trait locus |
| RS2147841010 |
SERPINA7
|
Health Risk |
association |
Thyroxine-binding globulin quantitative trait locus, Thyroxine-binding globulin quantitative trait locus |
| RS2147841568 |
SERPINA7
|
Health Risk |
Pathogenic |
Thyroxine-binding globulin quantitative trait locus, Thyroxine-binding globulin quantitative trait locus |
| RS2147841751 |
SERPINA7
|
Health Risk |
association |
Thyroxine-binding globulin quantitative trait locus, Thyroxine-binding globulin quantitative trait locus |
| RS2147842078 |
DLG3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 90 |
| RS2147842225 |
MED12
|
Health Risk |
Pathogenic |
Cholestasis-pigmentary retinopathy-cleft palate syndrome, Cholestasis-pigmentary retinopathy-cleft palate syndrome |
| RS2147842365 |
DLG3
|
Health Risk |
Likely pathogenic |
See cases, Thyroid cancer |
| RS2147844739 |
MED12
|
Health Risk |
Likely pathogenic |
— |
| RS2147844887 |
MED12
|
Health Risk |
Likely pathogenic |
FG syndrome 1, Blepharophimosis - intellectual disability syndrome |
| RS2147845271 |
NKAP
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, X-linked |
| RS2147849728 |
COL4A5
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS2147849915 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147849950 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147850123 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147850264 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2147852182 |
DOCK6
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 2, Adams-Oliver syndrome 2 |
| RS2147853237 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Aminoglycoside-induced deafness |
| RS2147855177 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147856928 |
BRWD3
|
Health Risk |
Likely pathogenic |
— |